Merck & Co. (MRK)
(Delayed Data from NYSE)
$116.60 USD
+0.05 (0.04%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $116.55 -0.05 (-0.04%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Revenue - Line of Business Segments | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|---|
Sales: Cardiovascular: Adempas [$... |
-- | 255 | 238 | 252 | 220 | 215 |
Sales: Neuroscience: Belsomra [$M... |
-- | 231 | 258 | 318 | 327 | 306 |
Sales: Animal Health: Livestock [... |
-- | 3,337 | 3,300 | 3,295 | 2,939 | 2,784 |
Sales: Animal Health: Companion A... |
-- | 2,288 | 2,250 | 2,273 | 1,764 | 1,609 |
Sales: Hospital Acute Care: Zerba... |
-- | 218 | 169 | -1 | 130 | 121 |
Sales: Cardiovascular: Alliance r... |
-- | 367 | 341 | 342 | 281 | 204 |
Sales: Hospital Acute Care: Prevy... |
-- | 605 | 428 | 370 | 281 | 165 |
Sales: Virology: Lagevrio [$M] |
-- | 1,428 | 5,684 | 952 | -- | -- |
Sales: Hospital Acute Care: Dific... |
-- | 302 | 263 | 175 | -- | -- |
Sales: Vaccines: Vaxneuvance [$M] |
-- | 665 | 170 | -- | -- | -- |
Sales: Pharmaceutical [$M] |
-- | 53,583 | 52,005 | 42,754 | 36,610 | 41,751 |
Sales: Other Revenues [$M] |
-- | 907 | 1,728 | 382 | 182 | 521 |
Sales: Virology: Isentress [$M] |
-- | 483 | 633 | 769 | 857 | 975 |
Sales: Diabetes: Janumet [$M] |
-- | 1,177 | 1,700 | 1,964 | 1,971 | 2,041 |
Sales: Diabetes: Januvia [$M] |
-- | 2,189 | 2,813 | 3,324 | 3,306 | 3,482 |
Sales: Hospital Acute Care: Noxaf... |
-- | 213 | 238 | 259 | 329 | 662 |
Sales: Diabetes: Other Pharmaceut... |
-- | 2,283 | 2,319 | 2,118 | 2,312 | 696 |
Sales: Immunology: Remicade [$M] |
-- | 187 | 207 | 299 | 330 | 411 |
Sales: Immunology: Simponi [$M] |
-- | 710 | 706 | 825 | 838 | 830 |
Sales: Animal health [$M] |
-- | 5,625 | 5,550 | 5,568 | 4,703 | 4,393 |
Sales: Oncology: Keytruda [$M] |
-- | 25,011 | 20,937 | 17,186 | 14,380 | 11,084 |
Sales: Oncology: Alliance Revenue... |
-- | 1,199 | 1,116 | 989 | 725 | 444 |
Sales: Oncology: Alliance revenue... |
-- | 960 | 876 | 704 | 580 | 404 |
Sales: Oncology: Alliance revenue... |
-- | 212 | 166 | 17 | -- | -- |
Sales: Vaccines: Gardasil [$M] |
-- | 8,886 | 6,897 | 5,673 | 3,938 | 3,737 |
Sales: Vaccines: ProQuar/M-M-R II... |
-- | 2,368 | 2,241 | 2,135 | 1,878 | 2,275 |
Sales: Vaccines: RotaTeq [$M] |
-- | 769 | 783 | 807 | 797 | 791 |
Sales: Vaccines: Pneumovax [$M] |
-- | 412 | 602 | 893 | 1,087 | 926 |
Sales: Vaccines - Total [$M] |
-- | 13,654 | 11,297 | 10,132 | 8,257 | 8,368 |
Sales: Hospital Acute Care: Bridi... |
-- | 1,842 | 1,685 | 1,532 | 1,198 | 1,131 |
Revenue - Geographic Segments | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
Sales: Hospital Acute Care: Bridi... |
-- | 1,156 | 922 | 762 | 583 | 533 |
Sales: Diabetes: Januvia - U.S. [... |
-- | 1,151 | 1,248 | 1,404 | 1,470 | 1,724 |
Sales: Diabetes: Janumet - U.S. [... |
-- | 223 | 355 | 367 | 477 | 589 |
Sales: Cardiovascular: Adempas - ... |
-- | 255 | 238 | 252 | 220 | 215 |
Sales: Neuroscience: Belsomra - U... |
-- | 81 | 79 | 78 | 81 | 92 |
Sales: Neuroscience: Belsomra - I... |
-- | 150 | 179 | 241 | 247 | 214 |
Sales: Animal Health: Livestock -... |
-- | 700 | 710 | 667 | 612 | 582 |
Sales: Animal Health: Livestock -... |
-- | 2,637 | 2,590 | 2,628 | 2,327 | 2,201 |
Sales: Animal Health: Companion A... |
-- | 1,104 | 1,112 | 1,091 | 872 | 724 |
Sales: Animal Health: Companion A... |
-- | 1,184 | 1,138 | 1,182 | 892 | 885 |
Sales: Hospital Acute Care: Zerba... |
-- | 119 | 89 | 4 | 74 | 63 |
Sales: Hospital Acute Care: Zerba... |
-- | 100 | 79 | -5 | 56 | 58 |
Sales: Cardiovascular: Alliance r... |
-- | 350 | 329 | 312 | 259 | 194 |
Sales: Cardiovascular: Alliance r... |
-- | 16 | 12 | 30 | 22 | 10 |
Sales: Hospital Acute Care: Prevy... |
-- | 264 | 188 | 153 | 119 | 84 |
Sales: Hospital Acute Care: Prevy... |
-- | 341 | 240 | 218 | 162 | 81 |
Sales: Virology: Lagevrio - U.S. ... |
-- | 10 | 1,523 | 632 | -- | -- |
Sales: Virology: Lagevrio - Inter... |
-- | 1,418 | 4,161 | 320 | -- | -- |
Sales: Hospital Acute Care: Dific... |
-- | 274 | 241 | 166 | -- | -- |
Sales: Hospital Acute Care: Dific... |
-- | 28 | 22 | 10 | -- | -- |
Sales: Pharmaceutical - U.S. [$M] |
-- | 26,539 | 24,989 | 20,401 | 18,010 | -- |
Sales: Pharmaceutical - Internati... |
-- | 27,044 | 27,016 | 22,353 | 18,600 | -- |
Sales: Diabetes: Other pharmaceut... |
-- | 688 | 693 | 841 | 984 | -- |
Sales: Diabetes: Other pharmaceut... |
-- | 1,596 | 1,628 | 1,275 | 1,328 | -- |
Sales: Other revenues - U.S. [$M... |
-- | 137 | 395 | 266 | 71 | -- |
Sales: Other revenues - Internati... |
-- | 770 | 1,333 | 116 | 111 | -- |
Geographic Revenue: International... |
-- | 31,635 | 32,077 | 26,279 | 21,930 | -- |
Sales: Vaccines: Vaxneuvance - U.... |
-- | 561 | 163 | -- | -- | -- |
Sales: Vaccines: Vaxneuvance - In... |
-- | 103 | 7 | -- | -- | -- |
Geographic Revenue: United States... |
-- | 28,480 | 27,206 | 22,425 | 19,588 | 20,519 |
Sales: Virology: Isentress - Inte... |
-- | 268 | 359 | 474 | 531 | 576 |
Sales: Diabetes: Janumet - Intern... |
-- | 954 | 1,344 | 1,597 | 1,494 | 1,452 |
Sales: Diabetes: Januvia - Intern... |
-- | 1,039 | 1,565 | 1,920 | 1,836 | 1,758 |
Sales: Vaccines: ProQuar/M-M-R II... |
-- | 531 | 518 | 506 | 500 | 592 |
Sales: Vaccines: Rotateq - Intern... |
-- | 276 | 275 | 334 | 311 | 284 |
Sales: Hospital Acute Care: Noxaf... |
-- | 32 | 51 | 60 | 42 | 282 |
Sales: Hospital Acute Care: Noxaf... |
-- | 181 | 187 | 199 | 287 | 380 |
Sales: Vaccines: ProQuad, M-M-R I... |
-- | 1,837 | 1,724 | 1,629 | 1,378 | 1,683 |
Sales: Vaccines: RotaTeq - U.S. [... |
-- | 493 | 508 | 473 | 486 | 506 |
Sales: Vaccines: Pneumovax - U.S.... |
-- | 127 | 346 | 547 | 727 | 679 |
Sales: Vaccines: Pneumovax - Inte... |
-- | 285 | 256 | 346 | 359 | 247 |
Sales: Virology: Isentress - U.S.... |
-- | 215 | 274 | 294 | 326 | 398 |
Sales: Animal health - U.S. [$M] |
-- | 1,804 | 1,822 | 1,758 | 1,484 | 1,306 |
Sales: Animal health - Internatio... |
-- | 3,821 | 3,728 | 3,810 | 3,219 | 3,086 |
Sales: Hospital Acute Care: Bridi... |
-- | 686 | 762 | 770 | 615 | 598 |
Sales: Oncology: Keytruda - U.S. ... |
-- | 15,114 | 12,686 | 9,765 | 8,352 | 6,305 |
Sales: Oncology: Keytruda - Inter... |
-- | 9,897 | 8,251 | 7,421 | 6,028 | 4,779 |
Sales: Oncology: Alliance revenue... |
-- | 607 | 584 | 515 | 417 | 269 |
Sales: Oncology: Alliance revenue... |
-- | 592 | 532 | 473 | 308 | 176 |
Sales: Oncology: Alliance revenue... |
-- | 657 | 579 | 417 | 359 | 239 |
Sales: Oncology: Alliance revenue... |
-- | 303 | 297 | 287 | 220 | 165 |
Sales: Oncology: Alliance revenue... |
-- | 168 | 123 | 0 | -- | -- |
Sales: Oncology: Alliance revenue... |
-- | 43 | 43 | 17 | -- | -- |
Sales: Vaccines: Gardasil - U.S. ... |
-- | 2,083 | 2,065 | 1,881 | 1,755 | 1,831 |
Sales: Vaccines: Gardasil - Inter... |
-- | 6,803 | 4,832 | 3,792 | 2,184 | 1,905 |